Clinical trial · Observational
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Diagnosis of Myomas
NCT04736095CI-TRIAL-00051966completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
• three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile chlorhexidine solution. A 3.3 mm soft plastic paediatric naso-gastric suction catheter was then passed through the cervix into the uterine cavity without grasping the cervix.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Fibroid | Leiomyoma | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 3D Ultrasound | Diagnostic Test | — | UNRESOLVED |
| Hysteroscopy | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 3D ultrasound for diagnosis of submucous myomas
- interventionNames
- Diagnostic Test: 3D Ultrasound
- label
- Hysteroscopy for diagnosis of submucous myoma
- interventionNames
- Diagnostic Test: Hysteroscopy
Primary outcomes (1)
- measure
- The accuracy of 3D ultrasound in doiagnosis of submucous myomas in comparison to hysteroscopy
- timeFrame
- one week
- description
- How many women will be diagnosed by 3D US to have submucous myoma
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * • Women between 20 and 60 years with abnormal uterine bleeding in form of heavy menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced two-dimensional ultrasonography with submucous fibroids. * Absence of STD, PID, active vaginal bleeding. Exclusion Criteria: * Presence of general cause of abnormal uterine bleeding * History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT) * History of recent hormonal treatment * High risk of undergoing hysteroscopy * Vaginal, Vulval causes of bleeding
References
Publications (0)
Data not yet available
No reference posted for this study.